Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jill Adler-Moore

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Current Opinion in Investigational Drugs (London, England : 2000)|April 3, 2003
Effect of tissue penetration on AmBisome efficacyJill Adler-Moore, Richard T Proffitt
The Journal of Antimicrobial Chemotherapy|January 22, 2002
AmBisome: liposomal formulation, structure, mechanism of action and pre-clinical experienceJill Adler-Moore, Richard T Proffitt
Frontiers in Bioscience : a Journal and Virtual Library|November 6, 2007
The VesiVax system: a method for rapid vaccine developmentGary Fujii, William Ernst, Jill Adler-Moore
Antimicrobial Agents and Chemotherapy|July 29, 2005
Functional interrelationships between cell membrane and cell wall in antimicrobial peptide-mediated killing of Staphylococcus aureusYan Q Xiong, Kasturi Mukhopadhyay, Michael R Yeaman, et al.
The Journal of Antimicrobial Chemotherapy|September 16, 2006
Comparison of antifungal treatments for murine fusariosisBrad Spellberg, Julie Schwartz, Yue Fu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 22, 2019
Clinical Pharmacokinetics, Pharmacodynamics, Safety and Efficacy of Liposomal Amphotericin BAndreas H Groll, Bart J A Rijnders, Thomas J Walsh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 22, 2019
Preclinical Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antifungal Activity of Liposomal Amphotericin BJill Adler-Moore, Russell E Lewis, Roger J M Brüggemann, et al.
Vaccine|June 9, 2022
Recombinant Aspergillus fumigatus antigens Asp f 3 and Asp f 9 in liposomal vaccine protect mice against invasive pulmonary aspergillosisMatthew Slarve, Nickolas Holznecht, Hernan Reza, et al.
Vaccine|May 7, 2011
Characterization of the murine Th2 response to immunization with liposomal M2e influenza vaccineJill Adler-Moore, Meilen Munoz, Hana Kim, et al.
Mbio|February 14, 2018
The Viscoelastic Properties of the Fungal Cell Wall Allow Traffic of AmBisome as Intact Liposome VesiclesLouise Walker, Prashant Sood, Megan D Lenardon, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Current Opinion in Investigational Drugs (London, England : 2000)|April 3, 2003
Effect of tissue penetration on AmBisome efficacyJill Adler-Moore, Richard T Proffitt
The Journal of Antimicrobial Chemotherapy|January 22, 2002
AmBisome: liposomal formulation, structure, mechanism of action and pre-clinical experienceJill Adler-Moore, Richard T Proffitt
Frontiers in Bioscience : a Journal and Virtual Library|November 6, 2007
The VesiVax system: a method for rapid vaccine developmentGary Fujii, William Ernst, Jill Adler-Moore
Antimicrobial Agents and Chemotherapy|July 29, 2005
Functional interrelationships between cell membrane and cell wall in antimicrobial peptide-mediated killing of Staphylococcus aureusYan Q Xiong, Kasturi Mukhopadhyay, Michael R Yeaman, et al.
The Journal of Antimicrobial Chemotherapy|September 16, 2006
Comparison of antifungal treatments for murine fusariosisBrad Spellberg, Julie Schwartz, Yue Fu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 22, 2019
Clinical Pharmacokinetics, Pharmacodynamics, Safety and Efficacy of Liposomal Amphotericin BAndreas H Groll, Bart J A Rijnders, Thomas J Walsh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 22, 2019
Preclinical Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antifungal Activity of Liposomal Amphotericin BJill Adler-Moore, Russell E Lewis, Roger J M Brüggemann, et al.
Vaccine|June 9, 2022
Recombinant Aspergillus fumigatus antigens Asp f 3 and Asp f 9 in liposomal vaccine protect mice against invasive pulmonary aspergillosisMatthew Slarve, Nickolas Holznecht, Hernan Reza, et al.
Vaccine|May 7, 2011
Characterization of the murine Th2 response to immunization with liposomal M2e influenza vaccineJill Adler-Moore, Meilen Munoz, Hana Kim, et al.
Mbio|February 14, 2018
The Viscoelastic Properties of the Fungal Cell Wall Allow Traffic of AmBisome as Intact Liposome VesiclesLouise Walker, Prashant Sood, Megan D Lenardon, et al.
Pageof 2